Cosman, Felicia http://orcid.org/0000-0003-4554-6616
Kendler, David L.
Langdahl, Bente L.
Leder, Benjamin Z.
Lewiecki, E. Michael
Miyauchi, Akimitsu
Rojeski, Maria
McDermott, Michele
Oates, Mary K.
Milmont, Cassandra E.
Libanati, Cesar
Ferrari, Serge
Funding for this research was provided by:
Amgen Inc.
UCB Pharma
Article History
Received: 21 April 2021
Accepted: 23 September 2021
First Online: 15 February 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: FC has received institutional grants and research support from Amgen, has served as a consultant for Amgen and Radius Health, and has served on the speakers’ bureaus for Amgen and Radius Health. DLK has received institutional grants and research support from Amgen and Radius Health; has served as a consultant for Amgen, Eli Lilly, and Pfizer; and has served on the speakers’ bureaus for Amgen and Eli Lilly. BLL has received institutional grants and research support from Amgen and Novo Nordisk; has served as a consultant for Amgen, UCB Pharma, Eli Lilly, Gedeon Richter, and Gilead; and has served on the speakers’ bureaus for Eli Lilly, Amgen, and UCB Pharma. BZL has received institutional grants and research support from Amgen and has served as a consultant for Amgen and Radius Health. EML has received research grants from Radius Health, Amgen, Mereo, and Bindex; income for service on scientific advisory boards or consulting for Amgen, Radius, Alexion, Sandoz, Samsung Bioepis, and Sanifit; income for service on speakers’ bureaus for Radius and Alexion; project development support for University of New Mexico; and royalties from UpToDate for sections on DXA, fracture risk assessment, and prevention of osteoporosis. He is a board member of the National Osteoporosis Foundation, International Society for Clinical Densitometry, and Osteoporosis Foundation of New Mexico. AM has served as a consultant for Amgen, Amgen Astellas BioPharma K.K., and Teijin Pharma. MR, MM, MKO, and CEM are employees and stockholders of Amgen. CL is an employee and stockholder of UCB Pharma. SF has received institutional grants and research support from Amgen, UCB Pharma, AgNovos, Alexion, and Labatec and has served as a consultant for Amgen, UCB Pharma, Alexion, AgNovos, Radius Health, and Labatec.